Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections
- 28 February 1991
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 14 (1) , 101-105
- https://doi.org/10.1016/0732-8893(91)90097-y
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics and tissue penetration of ceftibutenAntimicrobial Agents and Chemotherapy, 1990
- The in-vitro activity of ceftibuten against 475 clinical isolates of Gram-negative bacilli, compared with cefuroxime and cefadroxilJournal of Antimicrobial Chemotherapy, 1990
- In vitro activities and targets of three cephem antibiotics against Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1989
- Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogensAntimicrobial Agents and Chemotherapy, 1989
- In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of -lactamasesJournal of Antimicrobial Chemotherapy, 1989
- Ceftibuten (7432-S, SCH 39720): Comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelinesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporinAntimicrobial Agents and Chemotherapy, 1988
- In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogensJournal of Antimicrobial Chemotherapy, 1988